Introduction
When massive hemoptysis is untreated, it has a mortality rate of over 50 percents. It is considered as one of most dreaded of all respiratory emergencies and can have a variety of underlying causes.
Bronchial artery embolization (BAE) was first reported in 1973 by Remy1 and it has become an established procedure in the management of massive and recurrent hemoptysis. Its efficacy is widely documented thereafter by number of articles [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] . An immediate control of hemoptysis is achieved in 73 to 98%, with a mean follow of less than one month [1] [2] [3] [4] . Immediate success rates have increased recently because of the introduction of superselective embolization and the refinement of embolic agents and techniques 4 . However, the long-term success rate of BAE is known to be unfavorable. Longterm recurrence rates are reported to be 10 to 52%, with a mean follow up period ranging from one to 46 months [1] [2] [3] [4] [5] [6] [7] .
The variety of factors influencing that control failure has been described. The recurrence of massive hemoptysis after BAE was defined that a gross hemoptysis more than 100 cc amount of blood occurred again which needed to undergo treatments such as BAE or lung resection surgery.
Demographic characteristics such as gender, age, the duration of symptom, the amount of hemoptysis, previous history of treatment for hemoptysis, the main medical condition causing hemoptysis, bilaterality of pulmonary lesion, the number of feeding vessels, and the presence of pleural thickening were our parameters analyzed. showed same results as univariate analysis (Table 5 ).
Discussion
We analyzed the result of BAE in our institution during a long period. In previous literatures, longterm recurrence rate have been reported to be 10 to 52%, with a mean follow up period ranging from one to 46 months [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] .
Remy et al. Regarding the factor of recurrence after BAE, Osaki et al. 4 concluded that bronchiectatic change on CT scan and pulmonary-bronchial shunt had some statistical significance. Kim et al. In this study, the amount of hemoptysis had some statistical relation with the recurrent event.
Though the analysis of underlying disease had no statistical significance, active tuberculosis tended to have more control rate compared to aspergilloma and cancer. The effective anti-tuberculosis drug therapy must have reduced the recurrent hemoptysis but its relatively modest prevalence in our series (30% compared to 43-52% in other domestic studies) 5, 6, 12, 14 lead to overall no statistical significance.
The fact that bilaterlity of lesion on initial chest X-ray was higher in relapse group can be explained by the extent of the lung disease accounts for more serious pathology as it was commented by Kim et al. 6 In 1993, Tamura et al. 8 females) medical records were analyzed retrospectively during a mean follow up period of 20.4 months (ranging from 1 month to 54 months).
Results :
Among 66 patients whose data were available, 23 (34.9%) patients had recurrent major hemoptysis.
Patients' age, sex, underlying disease, previous intervention history, and number of feeding vessels had no statistical validity as risk factors of recurred major hemoptysis. But bilaterality of lesion, amount of hemoptysis, and pleural thickening were revealed as meaningful factors for predicting relapse (p = 0.008, 0.018, and 0.001, respectively).
Conclusion :
According to our series, patients presenting with larger amount of hemoptysis, pleural thickening of chest radiography and bilateral lesion are associated with increased risk of major hemoptysis in patients treated with BAE.
